tirzepatide drug shortage list Lilly CEO says weight-loss to end 'very soon', Bloomberg News reports fda and tirzepatide shortage 🚨

AI use can be associated with weight gain that can lead to increased cardiometabolic risk

And over 150,000 members providing a large operational base

Signals are compelling enough to demand conversation and monitoring, even if definitive rules are not established

doi: 10.1001/jama.2025.2975

10.1038/s41556-018-0250-9 Nat

Lifestyle Recommendations for GLP-1 Agonists From a nutritional standpoint, there are three areas of concern related to using GLP-1 agonists: Malnutrition due to decreased food intake Digestive complaints Muscle-wasting GLP-1 agonists can produce a significant reduction in appetite, or they cause some nausea as well